LRCX vs ZBH · P/E 71, rev $23.23B vs P/E 23, rev $8.23B
Lam Research Corp (LRCX) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ. It is led by Timothy M. Archer.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Latest reported ZBH revenue for 2025-12-31 was $8.23B. Net income was $705.1M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
LRCX currently screens at market cap $467.94B and trailing P/E 70.9. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the LRCX and ZBH stock pages for the full models.
Not investment advice.